2
Length of ICU stay reduced by 32% Complications reduced by 36% Optimized Hemodynamic Therapy in Cardiac Surgery Patients Early goal-directed therapy reduces intensive care stay after cardiac surgery Extravascular Lung Water Index (ELWI) can serve as a warning parameter for volume overload Fluid Management: timing is everything! Individualise your treatment Control Group Control Group Study Group Study Group

Goepfert Paper

  • Upload
    zomwe

  • View
    1

  • Download
    0

Embed Size (px)

DESCRIPTION

Goepfert Paper

Citation preview

  • Length of ICU stayreduced by

    32%

    Complications reduced by

    36%

    Optimized Hemodynamic Therapy in Cardiac Surgery Patients

    32%36%

    Early goal-directed therapy reduces intensive care stay after cardiac surgery

    Extravascular Lung Water Index (ELWI) can serve as a warning parameter for volume overload

    Fluid Management: timing is everything!

    Individualise your treatment

    Control Group Control GroupStudy Group Study Group

  • Authors GoepfertMS,RichterHP,EulenburgCZ,GruetzmacherJ,RafflenbeulE,RoeherK, Sandersleben AV, Diedrichs S, Reichenspurner H, Goetz AE, Reuter DACenter Hamburg-Eppendorf, GermanyJournal Anesthesiology 2013; epubStudy Type Prospective Randomised Controlled TrialHypothesis Goal-directed hemodynamic therapy, based on the combination of functional and volumetric hemodynamic parameters, improves outcome in patients with cardiac surgery.Surgeries Coronary Artery Bypass Grafting (CABG), Aortic Valve Replacement (AVR), CABG + AVRTechnology PiCCO Monitor with PiCCO femoral artery catheter Study Group (SG) Control Group (CG) No of patients 50 50 GDT parameters SVV, GEDI, ELWI, CI, MAP MAP, CVP, HR

    Individually Optimized Hemodynamic Therapy Reduces Complications and Length of Stay in the Intensive Care Unit A Prospective, Randomised Controlled Trial

    P

    ULS

    ION

    11/

    2013

    M

    PI4

    105U

    S_R

    00

    STOP

    SVV10%

    Give volume until SVV10%

    (observe CI and ELWI)

    ELWI > 12 ml/kg or CI decreasing

    Consider diuretics

    Define optimal GEDI

    YES

    NO

    MAP > 65 [mmHg]

    YES

    NO

    HR > 50 [bpm]

    YES HR < 110 [bpm]

    YES OK

    CVP > 8 [mmHg]

    NO

    Pacing Orciprenaline

    Atropine

    NO

    Sedation Analgesia

    RBC Transfusion -Blockade

    AntiarrhytmicsNO YES

    Give volume until MAP > 65 [mmHg] or

    CVP > 8 [mmHg]

    Vasopressors Catecholamines

    Optimal GEDI reached or SVV10%

    YES

    NO

    CI > 2.0 [l/min/m-2]

    MAP > 65 [mmHg]

    Give volume until opt GEDI is reached

    orSVV10% (observe CI and ELWI)

    NO

    HR < 50 [bpm]

    NO

    Vasopressor

    HR 50-100 [bpm]

    NO

    Pacing Orciprenaline

    Atropine Analgesia Sedation

    -Blockers RBC Transfusion

    STOP

    ELWI > 12 ml/kg or CI decreasing

    Consider diuretics

    YESYES

    YES

    Pacing 90/min Orciprenaline

    Atropine

    NO

    Catecholamines

    Algorithm 1: SVV was used to optimize preload. After volume optimization, GEDI was measured and noted as optGEDI. Algorithm 2: The individually titrated optGEDI served as the goal for preload optimization in clinical situations where SVV was not feasible.

    Algorithm 3: Hemodynamic algorithm for patients in the control group

    Control Group

    Study Group

    GDT Goal Directed TherapySVV Stroke Volume VariationGEDI Global End-Diastolic Volume IndexELWI Extravascular Lung Water IndexCI Cardiac IndexMAP Mean Arterial PressureCVP Central Venous PressureHR Heart Rate

    PULSION Medical Systems SE Hans-Riedl-Str. 17 85622 Feldkirchen, GermanyTel. +49 (0)89 45 99 14-0 Fax +49 (0)89 45 99 [email protected] www.PULSION.com

    PULSION Medical Inc. 3781AttucksDrivePowell,Ohio43065USATollfree:[email protected]